Grant: DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
University of Calgary
$120,000.00
Elucidating lung microbiota and bronchoalveolar macrophage interactions that drive bronchiectasis exacerbations using a novel microfluidic human lung-on-a-chip platform
FY 2025-26
Summary
Bronchiectasis, considered the most neglected disease in respiratory medicine, is a chronic lung disease that causes repeated infections and long-term inflammation. It is the third most common airways disease, behind asthma and emphysema. It is believed to begin with a lung infection that triggers an ongoing immune response, which damages lung tissue and makes patients more vulnerable to future infections. Until recently, the lungs were thought to be sterile, but we now know they contain diverse communities of microbes. However, research into the lung microbiome is still limited, partly because traditional animal models do not accurately reflect the human lungs. This study will use advanced bacterial genomic, metabolic, and culture-based techniques to deeply characterize the lung microbiome in healthy individuals and patients with bronchiectasis, creating a detailed picture of both the organisms present and their functional activity to guide our mechanistic studies. We will use an innovative lung-on-a-chip model that mimics the human lung to mechanistically explore how healthy and bronchiectasis lung microbes interact with immune cells that reside within human airways. By understanding how these interactions drive inflammation during bronchiectasis flare-ups, periods where lung function declines and patients are sick, this research could help pave the way for new, personalized treatments that restore a healthy lung microbiome and reduce the frequency and severity of bronchiectasis flare-ups.
Department
Program
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
559853
Name
Kim Ariel J
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
DT1 (Biomedical and/or Clinical Research) CGRS Doctoral
Projecttitle
Elucidating lung microbiota and bronchoalveolar macrophage interactions that drive bronchiectasis exacerbations using a novel microfluidic human lung-on-a-chip platform
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Keyworddelim
Bronchiectasis; Lung Inflammation; Macrophages; Microbial Therapeutics; Microbiome; Organ-On-A-Chip; Respiratory Medicine
Abstract
Bronchiectasis, considered the most neglected disease in respiratory medicine, is a chronic lung disease that causes repeated infections and long-term inflammation. It is the third most common airways disease, behind asthma and emphysema. It is believed to begin with a lung infection that triggers an ongoing immune response, which damages lung tissue and makes patients more vulnerable to future infections. Until recently, the lungs were thought to be sterile, but we now know they contain diverse communities of microbes. However, research into the lung microbiome is still limited, partly because traditional animal models do not accurately reflect the human lungs. This study will use advanced bacterial genomic, metabolic, and culture-based techniques to deeply characterize the lung microbiome in healthy individuals and patients with bronchiectasis, creating a detailed picture of both the organisms present and their functional activity to guide our mechanistic studies. We will use an innovative lung-on-a-chip model that mimics the human lung to mechanistically explore how healthy and bronchiectasis lung microbes interact with immune cells that reside within human airways. By understanding how these interactions drive inflammation during bronchiectasis flare-ups, periods where lung function declines and patients are sick, this research could help pave the way for new, personalized treatments that restore a healthy lung microbiome and reduce the frequency and severity of bronchiectasis flare-ups.
Competitiondate
202511
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Kim, Ariel J
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~